These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21180771)

  • 1. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.
    Miller MA; Barkal L; Jeng K; Herrlich A; Moss M; Griffith LG; Lauffenburger DA
    Integr Biol (Camb); 2011 Apr; 3(4):422-38. PubMed ID: 21180771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Detection of Metalloprotease Activities in Complex Biological Samples Using the PrAMA (Proteolytic Activity Matrix Assay) Method.
    Conrad C; Miller MA; Bartsch JW; Schlomann U; Lauffenburger DA
    Methods Mol Biol; 2017; 1574():243-253. PubMed ID: 28315256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates.
    Yoneyama T; Gorry M; Miller MA; Gaither-Davis A; Lin Y; Moss ML; Griffith LG; Lauffenburger DA; Stabile LP; Herman JG; Vujanovic NL
    J Cancer; 2017; 8(19):3916-3932. PubMed ID: 29187866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
    Neumann U; Kubota H; Frei K; Ganu V; Leppert D
    Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of metalloprotease activities in cerebrospinal fluids of patients with neoplastic meningitis.
    Conrad C; Dorzweiler K; Miller MA; Lauffenburger DA; Strik H; Bartsch JW
    Fluids Barriers CNS; 2017 Aug; 14(1):22. PubMed ID: 28806983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Array-based in situ fluorescence assay for profiling multiplex matrix metalloproteinases activities in tissue section.
    Lei Z; Jian M; Wei J; Wang Y; Meng X; Wang Z
    Anal Chim Acta; 2019 Oct; 1078():112-118. PubMed ID: 31358208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array.
    Ng EX; Miller MA; Jing T; Lauffenburger DA; Chen CH
    Lab Chip; 2015 Feb; 15(4):1153-9. PubMed ID: 25553996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meprin β induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage.
    Wichert R; Scharfenberg F; Colmorgen C; Koudelka T; Schwarz J; Wetzel S; Potempa B; Potempa J; Bartsch JW; Sagi I; Tholey A; Saftig P; Rose-John S; Becker-Pauly C
    FASEB J; 2019 Nov; 33(11):11925-11940. PubMed ID: 31381863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed protease activity assay for low-volume clinical samples using droplet-based microfluidics and its application to endometriosis.
    Chen CH; Miller MA; Sarkar A; Beste MT; Isaacson KB; Lauffenburger DA; Griffith LG; Han J
    J Am Chem Soc; 2013 Feb; 135(5):1645-8. PubMed ID: 23157326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.
    Herzog C; Haun RS; Ludwig A; Shah SV; Kaushal GP
    J Biol Chem; 2014 May; 289(19):13308-22. PubMed ID: 24662289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput protease activity cytometry reveals dose-dependent heterogeneity in PMA-mediated ADAM17 activation.
    Wu L; Claas AM; Sarkar A; Lauffenburger DA; Han J
    Integr Biol (Camb); 2015 May; 7(5):513-24. PubMed ID: 25832727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using fluorogenic peptide substrates to assay matrix metalloproteinases.
    Fields GB
    Methods Mol Biol; 2010; 622():393-433. PubMed ID: 20135296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
    Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
    Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways.
    Dang M; Armbruster N; Miller MA; Cermeno E; Hartmann M; Bell GW; Root DE; Lauffenburger DA; Lodish HF; Herrlich A
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9776-81. PubMed ID: 23720309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding of klotho by ADAMs in the kidney.
    van Loon EP; Pulskens WP; van der Hagen EA; Lavrijsen M; Vervloet MG; van Goor H; Bindels RJ; Hoenderop JG
    Am J Physiol Renal Physiol; 2015 Aug; 309(4):F359-68. PubMed ID: 26155844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential in vivo zymography: a method for observing matrix metalloproteinase activity in the zebrafish embryo.
    Keow JY; Herrmann KM; Crawford BD
    Matrix Biol; 2011 Apr; 30(3):169-77. PubMed ID: 21292002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of Protease Activities Using Fluorogenic Substrates.
    Santamaria S; Nagase H
    Methods Mol Biol; 2018; 1731():107-122. PubMed ID: 29318548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
    Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
    Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
    Guo S; Peng M; Zhao Q; Zhang W
    Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
    Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
    Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.